Invenra Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Invenra Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014287
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, microarrays, and to produce the broadest epitope coverage. Invenra enables the screening of antibodies in phenotypic assays for biological activity and other desirable attributes. The company’s proprietary mAbSeq platform allows for selection of antibodies based on functional assays. It operates through research companies to discover novel therapeutic antibodies targeting cancer. Invenra is headquartered in Madison, Wisconsin, the US.

Invenra Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Invenra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Invenra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Invenra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Invenra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Invenra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Invenra Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Invenra Raises USD3 Million in Venture Financing 10
Invenra Raises USD3 Million in Venture Financing 11
Invenra Raises USD3 Million in Venture Financing 12
Invenra Raises USD2 Million in Venture Financing 13
Invenra Raises USD2 Million in Venture Financing 14
Invenra Raises US$3 Million In Venture Financing 15
Invenra Raises US$1.2 Million In Venture Financing 16
Partnerships 17
Invenra Enters into Agreement With Merck 17
Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 18
Invenra Enters into Agreement with Oxford BioTherapeutics 19
Invenra Inc – Key Competitors 20
Invenra Inc – Key Employees 21
Invenra Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Sep 26, 2017: Invenra Adds Experienced Clinical Immuno-oncologist, Dr. Paul Sondel to the Advisory Team 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Invenra Inc, Pharmaceuticals & Healthcare, Key Facts 2
Invenra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Invenra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Invenra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Invenra Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Invenra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Invenra Raises USD3 Million in Venture Financing 10
Invenra Raises USD3 Million in Venture Financing 11
Invenra Raises USD3 Million in Venture Financing 12
Invenra Raises USD2 Million in Venture Financing 13
Invenra Raises USD2 Million in Venture Financing 14
Invenra Raises US$3 Million In Venture Financing 15
Invenra Raises US$1.2 Million In Venture Financing 16
Invenra Enters into Agreement With Merck 17
Invenra Enters into Agreement with QIMR Berghofer Medical Research Institute 18
Invenra Enters into Agreement with Oxford BioTherapeutics 19
Invenra Inc, Key Competitors 20
Invenra Inc, Key Employees 21

★海外企業調査レポート[Invenra Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fisia Italimpianti SpA:企業の戦略的SWOT分析
    Fisia Italimpianti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Clarion Co Ltd:企業の戦略的SWOT分析
    Clarion Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Burger-In Oy:企業の戦略・SWOT・財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Eternygen GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research o …
  • Vectren Corp (VVC):石油・ガス:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Ingram Micro Inc.:企業のM&A・事業提携・投資動向
    Ingram Micro Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ingram Micro Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • CDK Global, Inc. (CDK):企業の財務・戦略的SWOT分析
    CDK Global, Inc. (CDK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • EA Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Equinor ASA (EQNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • The Jackson Laboratory-製薬・医療分野:企業M&A・提携分析
    Summary The Jackson Laboratory (JAX) is a nonprofit biomedical research institution that offers genomic solutions. The institution offers services in the therapeutic areas of cardiovascular, metabolic diseases, oncology, rare diseases, and neurobiology. It offers breeding and rederivation services, …
  • ArcelorMittal:企業のM&A・事業提携・投資動向
    ArcelorMittal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ArcelorMittal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Laird PLC (LRD):企業の財務・戦略的SWOT分析
    Laird PLC (LRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TranSystems Corporation:企業の戦略・SWOT・財務情報
    TranSystems Corporation - Strategy, SWOT and Corporate Finance Report Summary TranSystems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Apple Inc:企業の戦略・SWOT・財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Corium International Inc (CORI):企業の財務・戦略的SWOT分析
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Mgm China Holdings Ltd:企業の戦略・SWOT・財務分析
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆